Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 10/30 01:25:34 pm
127.1 EUR   -4.08%
01:10pMERCK KGAA : Sell rating from Goldman Sachs
MD
10/29MERCK : Mammoth Biosciences Partner to Produce, Scale Up Covid-19 Test
DJ
10/28MERCK KGAA : Kepler Cheuvreux remains its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Communiqués de presse de la société MERCK KGAA
10/27MERCK : MAVENCLAD® (cladribine tablets) is available through public drug plans f..
AQ
10/15Global Glycobiology Market to Rise at 14.64% between 2020 and 2027
AQ
10/08MERCK : MilliporeSigma Celebrates Topping-Out Ceremony for New Membrane Producti..
AQ
10/07MERCK KGAA : - MilliporeSigma Inaugurates New, Upgraded Onsite Industrial Water ..
AQ
09/30PFIZER : When Are Recombinant Proteins Structurally Different Than Their Natural..
AQ
09/30BIOGEN : Merck - Press Release as a Result of the Ad-hoc Announcement of Septemb..
AQ
09/29MERCK KGAA : Merck KGaA reverses provision for lawsuit in the amount of EUR 365 ..
EQ
09/28IPSEN : appoints Philippe Lopes-Fernandes as Executive Vice President, Chief Bus..
AQ
09/21MERCK : Darmstadt, Germany, Opens State-of-the-art Research Center for Electroni..
PU
09/18MERCK : Agenda
PU
09/18MERCK : BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The ..
PU
09/14MERCK KGAA : Darmstadt, Germany Announces Positive Phase II Results for Investig..
AQ
09/13MERCK : Darmstadt, Germany, Advances Oncology Portfolio and Pipeline with New an..
PU
09/10MERCK : Darmstadt, Germany Announces Positive Phase II Results for Investigation..
PU
09/09MERCK : Darmstadt, Germany, Announces € 59 Million Antibody-Drug Conjugate Manuf..
PU
09/04MERCK : EMD Serono to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting..
AQ
09/03MERCK : Darmstadt, Germany to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020..
PU
08/26MERCK : FDA Accepts Filing of New Drug Application for Tepotinib for the Treatme..
AQ
08/26SUTRO BIOPHARMA : Earns Clinical Supply Milestone Payment from Merck KGaA, Darms..
AQ
08/14Growing R&D Activities to Push the Global Protein Expression Market to Garner..
AQ
08/12MERCK : Q2 2020 Financial Summary for Investors and Analysts
PU
08/12MERCK : Financial Statements Q1 2019 – Q2 2020
PU
08/12MERCK : Financial Statement (XLS)
PU
08/12SECOND QUARTER : Group Remains on Course in a Challenging Environment
PU
08/12MERCK : Half-yearly Financial Report 2020
PU
08/06MERCK : Leadership Change within Group Communications at Merck KGaA, Darmstadt, ..
PU
08/06SECOND QUARTER : Group Remains on Course in a Challenging Environment
PU
08/06Q2 20 ANALYST CALL, AUGUST 06, 2020, : 00pm CET
PU
08/05MERCK : Darmstadt, Germany statement on Rebif® (interferon beta-1a) contribution..
PU
07/13MERCK : Changes in Merck KGaA, Darmstadt, Germany, Executive Board
PU
07/10MERCK : Darmstadt, Germany Announces Opening of its Life Science Business' Large..
PU
07/01MERCK : Darmstadt, Germany, Receives EU Commission Supplementary Statement of Ob..
PU
06/30MERCK : FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients w..
PU
06/25MERCK : Darmstadt, Germany, Initiates First Clinical Trial of TLR7 and 8 Inhibit..
PU
06/24PFIZER : Oncolytics Biotech Doses First Patient in Phase 2 BRACELET-1 Study Eval..
AQ
06/23MERCK : Q1 2020 Roadshow Zurich/Geneva
PU
06/22MERCK : European Medicines Agency Validates Application for BAVENCIO® (avelumab)..
PU
06/11MERCK : Co-Existence Agreements – The Importance Of Getting Them Right
AQ
06/10MERCK : MilliporeSigma and 10x Genomics Launch Powerful New Option for CRISPR Re..
PU
06/09MERCK : EMD Serono Announces Launch of MS in the 21st Century Website in the U.S..
AQ
06/09MERCK : Liquid Crystal Windows business of Merck KGaA, Darmstadt, Germany, and G..
PU
05/29MERCK : New England Journal of Medicine Publishes Primary Analysis of VISION Dat..
PU
05/28MERCK : EMD Serono - Rebif U.S. Label Now Includes Pregnancy Outcomes and Lactat..
AQ
05/27MERCK : Darmstadt, Germany and Baylor College of Medicine Announce Collaboration..
PU
05/25MERCK : EMD Serono - New Late-Breaking Data at EAN Indicate Evobrutinib is the F..
AQ
05/25MERCK KGAA : Notification and public disclosure of transactions by persons
EQ
05/14Q1 20 EARNINGS - ANALYST CALL, MAY 1 : 00 pm CET
PU
05/14MERCK : Strong first quarter – low impact from Covid-19 to date
PU
05/13MERCK KGAA : Preliminary announcement of the publication of financial reports ac..
EQ
05/11MERCK : Darmstadt, Germany Announces Grants of U.S. Patents for Foundational CRI..
PU
05/11MERCK : MilliporeSigma Granted U.S. Patents for Foundational CRISPR-Cas9 Technol..
AQ
05/05MERCK : Domain Therapeutics receives development milestone payment from Merck KG..
AQ
05/01MERCK : EMD Serono - Data from EMD Serono at ASCO 2020 to Showcase Significant C..
AQ
04/30MERCK : Data from Merck KGaA, Darmstadt, Germany, at ASCO 2020 to Showcase Signi..
PU
04/23MERCK : Ronastar® Blue Lights – the new interference pigment for blue shim..
PU
04/23Immutep Limited - Enrollment completed for the INSIGHT-004 Study
AQ
04/22MERCK KGAA : Preliminary announcement of the publication of quarterly reports an..
EQ
04/22MERCK KGAA : Preliminary announcement of the publication of financial reports ac..
EQ
04/22MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
04/21MERCK : Darmstadt, Germany Announces Boost to Commercial Viral Vector and Gene T..
PU
04/16MERCK KGAA : Correction of a release from 15/04/2020 according to Article 40, Se..
EQ
04/15MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
04/10PFIZER : EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation a..
AQ
04/09MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
04/09MERCK : US FDA Breakthrough Therapy Designation and Submission of Application fo..
PU
04/07MERCK : Darmstadt, Germany, Awarded Second U.S. Patent for CRISPR Gene-Editing T..
PU
04/07MERCK : MilliporeSigma Awarded Second U.S. Patent for CRISPR Gene-Editing Techno..
AQ
04/07MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
04/02MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
03/26Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations..
AQ
03/25MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
03/23MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
03/20MERCK KGAA : - Combating the Spread of COVID-19
AQ
03/19MERCK : Darmstadt, Germany, statement on Rebif (interferon beta-1a) donation to ..
PU
03/18MERCK : Darmstadt, Germany, statement on upcoming clinicaltrials.gov updates for..
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on MERCK KGAA